Literature DB >> 16201714

Detection of cotinine in neonate meconium as a marker for nicotine exposure in utero.

N A Sherif1, S M Kamel, O S Al-Ashkar, O A Sharaki, E A Seif, E A Hegazy.   

Abstract

Neonate meconium cotinine level was evaluated as a marker of prenatal exposure to nicotine from tobacco smoking by mothers. Mothers admitted to a maternity hospital in Alexandria, Egypt, were divided into 3 groups: 10 active smokers, 10 passive smokers and 10 with no tobacco exposure during pregnancy. Urine and saliva samples were collected from mothers and first-day meconium samples from their neonates. Mean maternal urinary cotinine levels, measured using radioimmunoassay, differed significantly between the 3 groups, as did mean salivary cotinine and mean cotinine levels in meconium. There was a significant positive correlation between cotinine levels in meconium and both maternal urinary and salivary cotinine levels. Meconium is an ideal biological marker for testing direct fetal exposure to tobacco smoke in the neonatal period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16201714

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  7 in total

1.  Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits.

Authors:  Teresa R Gray; Rina D Eiden; Kenneth E Leonard; Gerard Connors; Shannon Shisler; Marilyn A Huestis
Journal:  Nicotine Tob Res       Date:  2010-04-28       Impact factor: 4.244

2.  An epidemiologic study comparing fetal exposure to tobacco smoke in three Southeast Asian countries.

Authors:  Enrique M Ostrea; Esterlita Villanueva-Uy; Sopapan Ngerncham; Luephorn Punnakanta; Melissa J P Batilando; Pratibha Agarwal; Elizabeth Pensler; Melissa Corrion; Erwin F Ramos; Joshua Romero; Ronald L Thomas
Journal:  Int J Occup Environ Health       Date:  2008 Oct-Dec

3.  Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes.

Authors:  Sarah K Himes; Laura R Stroud; Karl B Scheidweiler; Raymond S Niaura; Marilyn A Huestis
Journal:  J Pediatr       Date:  2012-12-01       Impact factor: 4.406

4.  Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Authors:  Teresa R Gray; Raquel Magri; Diaa M Shakleya; Marilyn A Huestis
Journal:  Clin Chem       Date:  2008-10-09       Impact factor: 8.327

5.  A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium.

Authors:  Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-02-26       Impact factor: 4.142

6.  Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry.

Authors:  Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-01-16       Impact factor: 3.205

7.  A prospective cohort study of biomarkers of prenatal tobacco smoke exposure: the correlation between serum and meconium and their association with infant birth weight.

Authors:  Joe M Braun; Julie L Daniels; Charles Poole; Andrew F Olshan; Richard Hornung; John T Bernert; Yang Xia; Cynthia Bearer; Dana Boyd Barr; Bruce P Lanphear
Journal:  Environ Health       Date:  2010-08-27       Impact factor: 5.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.